Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI    SAN   FR0000120578

SANOFI (SAN)

2319
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo SANOFI
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

The company operates through the following segments: Pharmaceuticals, Human Vaccines and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing.

The Animal Health segment comprises the research, development, production and marketing activities for vaccines.

It offers a range of medicines and vaccines on animal species.

The company was founded in 1994 and is headquartered in Paris, France.
Sales per Businesses
20122013Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals28,87182.6%27,25082.7% -5.95%
Vaccines3,89711.2%3,71611.3% -4.87%
Animal Health2,1796.2%1,9856% -9.77%
Sales per Regions
20122013Delta
EUR (in Million)%EUR (in Million)%
Rest of the World12,45135.6%11,44134.7% -8.83%
United States10,87331.1%10,43331.7% -4.22%
Europe8,21023.5%7,93324.1% -3.49%
France2,8468.1%2,5717.8% -10.7%
North America567.001.6%573.001.7% +1.05%
Managers
NameTitle
Serge WeinbergChairman of the Board
Jérôme ContamineChief Financial Officer
Christopher A. ViehbacherChief Executive Officer
Sébastien MartelInvestor Relations
Laure ThibaudCommunications
Surperformance© rating of SANOFI
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Shareholders
- Other shareholders 89,50%
- L'Oréal 8,93%
- Employees 1,30%
- Company-owned shares 0,27%
Advertisement
Sector Pharmaceuticals - Diversified
Trading RatingInvestor Rating
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
Sector Pharmaceuticals - Diversified
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- NYSE Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Stoxx 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2014 Factset    © 2014 Cofisem   
Dynamic quotes  
ON
| OFF